237 related articles for article (PubMed ID: 24828205)
41. Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs.
Shu J; Xia Z; Li L; Liang ET; Slipek N; Shen D; Foo J; Subramanian S; Steer CJ
RNA Biol; 2012 Oct; 9(10):1275-87. PubMed ID: 22995834
[TBL] [Abstract][Full Text] [Related]
42. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
Zhang BG; Li JF; Yu BQ; Zhu ZG; Liu BY; Yan M
Oncol Rep; 2012 Apr; 27(4):1019-26. PubMed ID: 22267008
[TBL] [Abstract][Full Text] [Related]
43. Dicer deficiency reveals microRNAs predicted to control gene expression in the developing adrenal cortex.
Krill KT; Gurdziel K; Heaton JH; Simon DP; Hammer GD
Mol Endocrinol; 2013 May; 27(5):754-68. PubMed ID: 23518926
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
[TBL] [Abstract][Full Text] [Related]
45. The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding miR-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.
Yu B; Ye X; Du Q; Zhu B; Zhai Q; Li XX
Cell Physiol Biochem; 2017; 41(6):2489-2502. PubMed ID: 28472810
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2.
Liao WT; Ye YP; Zhang NJ; Li TT; Wang SY; Cui YM; Qi L; Wu P; Jiao HL; Xie YJ; Zhang C; Wang JX; Ding YQ
J Pathol; 2014 Mar; 232(4):415-27. PubMed ID: 24293274
[TBL] [Abstract][Full Text] [Related]
47. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
Xiong B; Cheng Y; Ma L; Zhang C
Int J Oncol; 2013 Jan; 42(1):219-28. PubMed ID: 23174819
[TBL] [Abstract][Full Text] [Related]
48. Expression of dicer and its related miRNAs in the progression of prostate cancer.
Bian X; Shen Y; Zhang G; Gu C; Cai Y; Wang C; Zhu Y; Zhu Y; Zhang H; Dai B; Ye D
PLoS One; 2015; 10(3):e0120159. PubMed ID: 25768283
[TBL] [Abstract][Full Text] [Related]
49. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer.
Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
Cancer Lett; 2017 Jul; 399():53-63. PubMed ID: 28433598
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
51. Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α.
Fan Y; Li H; Ma X; Gao Y; Bao X; Du Q; Ma M; Liu K; Yao Y; Huang Q; Zhang Y; Zhang X
Oncotarget; 2016 Apr; 7(14):18280-94. PubMed ID: 26943772
[TBL] [Abstract][Full Text] [Related]
52. MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.
Yan SY; Chen MM; Li GM; Wang YQ; Fan JG
Tumour Biol; 2015 Jun; 36(6):4747-55. PubMed ID: 25647261
[TBL] [Abstract][Full Text] [Related]
53. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA-195 inhibits colorectal cancer cell proliferation, colony-formation and invasion through targeting CARMA3.
Wang L; Qian L; Li X; Yan J
Mol Med Rep; 2014 Jul; 10(1):473-8. PubMed ID: 24787958
[TBL] [Abstract][Full Text] [Related]
55. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1.
Yuan L; Zhou C; Lu Y; Hong M; Zhang Z; Zhang Z; Chang Y; Zhang C; Li X
Cancer Lett; 2015 Apr; 359(1):136-47. PubMed ID: 25592039
[TBL] [Abstract][Full Text] [Related]
56. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth.
Yan LX; Wu QN; Zhang Y; Li YY; Liao DZ; Hou JH; Fu J; Zeng MS; Yun JP; Wu QL; Zeng YX; Shao JY
Breast Cancer Res; 2011 Jan; 13(1):R2. PubMed ID: 21219636
[TBL] [Abstract][Full Text] [Related]
58. miR-19a promotes colorectal cancer proliferation and migration by targeting TIA1.
Liu Y; Liu R; Yang F; Cheng R; Chen X; Cui S; Gu Y; Sun W; You C; Liu Z; Sun F; Wang Y; Fu Z; Ye C; Zhang C; Li J; Chen X
Mol Cancer; 2017 Mar; 16(1):53. PubMed ID: 28257633
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
[TBL] [Abstract][Full Text] [Related]
60. MiR-202 inhibits the proliferation and invasion of colorectal cancer by targeting UHRF1.
Lin Y; Chen Z; Lin S; Zheng Y; Liu Y; Gao J; Chen S
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):598-606. PubMed ID: 31058289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]